Description

Success Stories From Small Molecule Drug Product

Success Stories From Small Molecule Drug Product Significant progress in CM implementation has been made over the last ten years. From fundamental studies within academia to global drug product CM approvals, CM represents a paradigm shift within the industry that will continue to grow with time. In this session, success stories from some of the early adopters and implementers will be shared which include regulatory, technical, and business-related achievements in the hope that it will encourage others to join the CM movement!

• Leveraging Continuous Manufacturing to Enable Real Time Release Testing
  Joseph Medendorp, Senior Director, Technical Operations
  Vertex  
• Particle Design and Engineering to Enable Continuous Direct Compression Manufacturing Processes
  Jeremy Merritt, PhD, Principal Research Scientist, Particle Design Lab – Small Molecule Design & Development
  Eli Lilly and Company Janssen
• CM-strategy: A Story of Multiple Platforms From R&D to Commercial
  Jeroen Geens, Engineering Technical Director – New Platforms
  Janssen

Moderator(s):

• Wyatt Roth, PhD, Senior Research Scientist, Eli Lilly and Company

Speaker(s):

• Joseph Medendorp, PhD, Senior Director, Technical Operations, Vertex
• Jeremy Merritt, PhD, Principal Research Scientist, Eli Lilly and Company
• Jeroen Geens, PhD, Engineering Technical Director, New Platforms, Janssen Research & Development